A Multicenter Prospective Clinical Trial for Reducing Remaining Submucous Fibroids Volume and Preventing Recurrence by Treating With GnRH Analogues or Mifepristone After Transcervical Resection of Type I-II Myoma
Latest Information Update: 14 Jun 2023
At a glance
- Drugs Goserelin (Primary) ; Mifepristone (Primary)
- Indications Uterine leiomyoma
- Focus Therapeutic Use
Most Recent Events
- 14 Jun 2023 New trial record